Nucleolar organizer regions and cervical intraepithelial neoplasia among women with human immunodeficiency virus infection. 1994

A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
Istituti di Clinica Ostetrica e Ginecologica and Anatomia Patologica, Università di Pavia, Policlinico S. Matteo, Italy.

OBJECTIVE Our purpose was to evaluate the proliferative activity of cervical intraepithelial neoplasia lesions in human immunodeficiency virus-seropositive women. METHODS The proliferative activity of cervical intraepithelial neoplasia lesions was measured by nucleolar organizer regions-associated proteins count. Twenty-two biopsy specimens of cervical intraepithelial neoplasia lesions from patients positive for human immunodeficiency virus were compared with 22 matched biopsy specimens obtained from controls negative for the virus. RESULTS The mean count of nucleolar organizer regions-associated proteins per cell was 9.5 +/- 3.7 (SD) in human immunodeficiency virus-positive patients and 7.6 +/- 2.8 in human immunodeficiency virus-negative controls (p < 0.0001 by Poisson test of heterogeneity of counts). The difference in counts between the two groups, which was confirmed by log-linear analysis, persisted within each severity stratum of cervical intraepithelial neoplasia and was independent of associated human papillomavirus infection. In human immunodeficiency virus-positive patients log-linear analysis showed that high-grade cervical intraepithelial neoplasia, the presence of human papillomavirus infection, and the severity of human immunodeficiency virus disease were independently correlated with increased nucleolar organizer regions-associated protein counts per cell. CONCLUSIONS The results of this study indicate that the proliferative activity of cervical intraepithelial neoplasia lesions of human immunodeficiency virus-positive patients was increased compared with matched lesions from human immunodeficiency virus-negative women. This finding suggests the possibility of an increased oncogenic progression of cervical intraepithelial neoplasia lesions in human immunodeficiency virus-positive patients.

UI MeSH Term Description Entries
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002578 Uterine Cervical Dysplasia Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE. Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervix Dysplasia,Dysplasia of Cervix Uteri,Neoplasia, Cervical Intraepithelial,Cervical Intraepithelial Neoplasia, Grade III,Cervical Intraepithelial Neoplasms,Intraepithelial Neoplasia, Cervical,Cervical Dysplasia, Uterine,Cervical Dysplasias,Cervical Intraepithelial Neoplasm,Cervix Uteri Dysplasia,Cervix Uteri Dysplasias,Dysplasia, Cervical,Dysplasia, Cervix,Dysplasia, Uterine Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D034961 Antigens, Nuclear Immunologically detectable substances found in the CELL NUCLEUS. Extractable Nuclear Antigen,Nuclear Antigen,Nuclear Antigens,Extractable Nuclear Antigens,Antigen, Extractable Nuclear,Antigen, Nuclear,Antigens, Extractable Nuclear,Nuclear Antigen, Extractable,Nuclear Antigens, Extractable

Related Publications

A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
January 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
January 2001, Pathology, research and practice,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
January 1992, European journal of gynaecological oncology,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
November 1988, Journal of clinical pathology,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
August 1993, Obstetrics and gynecology,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
April 2008, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
January 1996, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
March 1996, Obstetrics and gynecology,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
August 1994, American journal of obstetrics and gynecology,
A Spinillo, and P Tenti, and S Rao, and R Zappatore, and S Romagnoli, and G Pizzoli
February 1989, American journal of obstetrics and gynecology,
Copied contents to your clipboard!